The alveolar deadspace as a fraction of alveolar ventilation (VD alv /VT alv 
Pulmonary and cardiovascular disease commonly increase the pulmonary deadspace fraction, increasing the work of breathing, and thus making weaning from mechanical ventilation more difficult 1, 2 . However, the pulmonary deadspace fraction is infrequently estimated on the Intensive Therapy Unit (ITU) because it is time consuming and technically difficult. The arterial to end-tidal PCO 2 gradient (P a-E′ CO 2 ) gives some guidance to the deadspace fraction 3 and this may predict outcome in perioperative patients and ventilated neonates 4, 5 . Nunn and Hill related this gradient to the alveolar deadspace 6 . We have developed an original physiological simulator [7] [8] [9] [10] and have used it to examine theoretically the relationship between P a-E′ CO 2 and the alveolar deadspace fraction.
MATERIALS AND METHODS
The Nottingham Physiology Simulator (NPS) is a computer simulation of original physiological models.
Several components of the respiratory model simulation have been validated and are described in detail elsewhere 7, 9 . The models use "iterative resolution" or "progressive approximation" to resolve stable physiological solutions to input data. The deadspace aspect of the models has four compartments comprising (1) equipment and (2) anatomical (serial) deadspaces, (3) true alveolar (parallel) deadspace and (4) variably perfused and variably ventilated alveoli. The pulmonary contents are calculated progressively through the respiratory cycle. Alveolar contents are continuously modified by the passage of pulmonary blood and by inward or outward flow of gas. A timeslicing technique is used to derive true equilibria between "packets" of blood and the alveolar contents using iterative resolution. Inward and outward flows during a timeslice (e.g. 250 ms) are determined as follows: flow=K x (mouth-alveolar pressure)/resistance to flow x 60000/timeslice) where K is a constant. During exhalation, alveolar gas (a mixture gas from the perfused and non-perfused alveoli) displaces serial deadspace gas and lung volume falls. Time constants of the perfused and non-perfused alveoli are assumed constant throughout the respiratory cycle such that gas exhaled after the serial deadspace has been voided is constant in composition. During inhalation, fresh gas saturated with water vapour enters the serial deadspace, displacing its contents into the alveoli. The resulting alveolar oxygen fraction in the non-perfused alveoli is generated as follows when inward flow exceeds serial deadspace volume: FAO 2 (non-perfused alveoli)=(volume of O 2 in non-perfused alveoli before inward flow)+ (volume of O 2 in serial deadspace before inward flow+FIO 2 x(inward flow-serial deadspace volume))x(VD alv /VT alv ))/(total volume of nonperfused alveoli after inward flow) where VD alv / VT alv represents alveolar deadspace as a fraction of alveolar ventilation. Flow of blood past the perfused and ventilated alveoli during one timeslice is calculated as: flow (perfused and ventilated)=(1-shunt fraction)xcardiac output/(60000/timeslice). Alveolar oxygen tension (in non-perfused alveoli, for example) is calculated as follows: PAO 2 (non-perfused alveoli)=intra-thoracic pressure x (volume of O 2 in non-perfused alveoli)/(total volume of non-perfused alveoli). The alveolar and pulmonary capillary partial pressures of oxygen, carbon dioxide and nitrogen are then progressively calculated for each lung region by repeatedly transferring small packets of gas in the direction of the pressure gradient until the gradient for each is negligible. The model performs the above calculations for each lung region repeatedly, refining the values until steady-state is reached.
Alveolar deadspace was considered as a fraction of alveolar tidal volume (VD alv / VT alv ) rather than total tidal volume (VD alv /VT). The relationship between P a-E′ CO 2 and VD alv /VT alv under normal physiological conditions (Table 1 ) was established by recording P a-E′ CO 2 during step increases of 5% in the simulation's alveolar deadspace fraction from 0% to 50% of tidal volume (0% to 62.5% of VT alv when anatomical deadspace is 20% of tidal volume). The relationship between P a-E′ CO 2 and VD alv /VT alv was examined in the same fashion while the factors given in Table 1 were varied through a range of values (Table 1 , column 3). Findings from the examination of P a-E′ CO 2 prompted the examination of the relationship between VD alv /VT alv and the ratio (P a-E′ CO 2 )/P a CO 2 . The same factor analysis protocol was used to examine this relationship. Normal physiological values assumed in the study are given in Table 1 .
RESULTS
The arterial to end-tidal PCO 2 gradient (P a-E′ CO 2 ) had a non-linear relationship with VD alv /VT alv ( Figure 1a-1c) , the gradient increasing as VD alv / VT alv increased. All of the factors analysed except anatomical deadspace fraction caused alteration of the relationship between P a-E′ CO 2 and VD alv /VT alv (Figures 1a-1c) .
The relationship between (P a-E′ CO 2 )/P a CO 2 and VD alv /VT alv was more linear in all the situations tested (Figure 2a and 2b). During normal physiological conditions (Table 1) , VD alv /VT alv was most closely described by equation 1: VD alv /VT alv =1.135x(P a-E′ CO 2 )/P a CO 2 -0.005 (r=0.999). The only factors that caused significant departure of the curve from that constructed under normal conditions (Table 1) 
DISCUSSION
Disease states affect alveolar deadspace more than anatomical deadspace 11 and serial measurements may allow monitoring of disease progression. Deadspace increases the work of breathing required to achieve a given level of gas exchange, and an increase in pulmonary deadspace is thus a recognised cause of failure to wean from mechanical ventilation 1, 2 . Prediction of pulmonary deadspace may allow prediction of success or failure in weaning. Anatomical deadspace may be modified by altering equipment deadspace or by performing a tracheostomy, but usually remains relatively constant in each individual. The ratio VD alv /VT alv is used in this study since it provides a better method of quantifying gas exchange than VD alv /VT or physiological deadspace fraction (VD phys /VT). Its clinical applicability is the same as for VD alv /VT, but it is likely to have a closer Collection of exhaled gas in a Douglas bag allows the calculation of physiological deadspace via Enghoff's modification of the Bohr equation 11 . This value has been demonstrated to be useful as a criterion for weaning 1 . However, estimation of the alveolar deadspace is difficult. Fowler's method of estimating the anatomical deadspace fraction utilizes a geometric dissection of the expiratory concentration vs volume capnogram, and in combination with the Bohr-Enghoff equation allows estimation of alveolar deadspace 11 . This method is time consuming and difficult and is rarely used in clinical practice 12 . Estimation of anatomical and alveolar deadspace has been described via a single breath CO 2 method 13, 14 , but this method requires additional equipment and has been validated only in animals under limited physiological conditions. Attempts have also been made to correlate pulmonary deadspace with the results of bedside tests and epidemiological factors 15, 16 and to estimate pulmonary deadspace by indirect calorimetry 17 . Sophisticated attempts have been made to integrate data from ventilated patients and to predict patient data including pulmonary deadspace 18 . Results were encouraging, but it is difficult to draw meaningful conclusions from limited patient data about the validity of a technique across a spectrum of physiological states.
An assumption commonly made in modelling pulmonary physiology is that the PCO 2 in unperfused alveolar units is equal to the PCO 2 of inspired gas. The influence of (a) serial deadspace and (b) venous admixture fractions on the relationship between (P a-E′ CO 2 )/P a CO 2 and VDalv/VTalv. This is untrue, even in those truly unperfused alveoli. Serial (anatomical and equipment) deadspace contains a mixture of gas from perfused and nonperfused alveoli. These contents subsequently form part of the contents of deadspace alveoli since serial deadspace is in series with alveolar deadspace. It is thus difficult to estimate the contents of deadspace alveoli unless an iterative analysis is undertaken. The error caused by making the above assumption when modelling end-tidal CO 2 causes an underestimation of P E′ CO 2 of 3% in the healthy subject (calculated using the NPS), but the error rises to 10% if alveolar deadspace fraction is increased to 0.3 or if serial deadspace fraction is similarly increased. Some assumptions must be made within the respiratory model to allow the simulator to work in realtime. First, the intrapulmonary O 2 consumption and CO 2 production (VO 2 and VCO 2 ) are negligible. Previous studies in this area have also made this assumption. Most pulmonary metabolism will be satisfied by bronchial arterial and venous supply and drainage and should not affect deadspace or shunt calculation. Myburgh et al debated the existence of a significant intrapulmonary VO 2 19 . It is unlikely that intrapulmonary VO 2 in a normal subject will significantly affect results. Second, left to right shunt fraction is negligible. In the absence of intracardiac shunting the left to right shunt fraction is effectively zero. Third, the time constants of perfused and nonperfused alveolar units are equal. Deadspace alveolar units have a ventilation/perfusion ratio greater than unity. The usual cause of this in disease is a reduction in perfusion rather than an increase in ventilation. If the time constants for deadspace alveolar units are smaller than those for non-deadspace alveolar units then the deadspace will empty before the nondeadspace alveoli and P E′ CO 2 will be closer to non-deadspace P a CO 2 than that predicted by the simulation, causing an underestimation of alveolar deadspace fraction. Scatter of time constants will cause a sloping phase III of the expiratory capnogram, but if time constants of deadspace and nondeadspace alveolar units are scattered evenly then P E′ CO 2 will not be affected. Use of equation 1 in estimating VD alv /VT alv in patients with a significantly sloping phase III is thus of unproven validity.
Our theoretical analysis assumes a fixed P E′ CO 2 for a given set of physiological circumstances. Within the simulation, P E′ CO 2 is determined by alveolar deadspace fraction and by CO 2 tensions in deadspace and non-deadspace alveolar units. In practice, however, P E′ CO 2 may be measured at different sites within a breathing system, giving different values 20, 21 . Continuous capnography may also generate erroneous values for P E′ CO 2 since incomplete exhalation may yield a mixture of serial deadspace gas and alveolar gas, causing a falsely low reading. To overcome these difficulties, P E′ CO 2 should be measured at a standardized site within the breathing system and complete exhalation should be encouraged whenever possible by the use of an adequate expiratory time. Despite these potential difficulties in the interpretation of single values for P E′ CO 2 , trends within subjects are likely to be accurate if constant conditions are applied.
Our results demonstrate that the arterial to endtidal CO 2 gradient is likely to be an unreliable indicator of the alveolar deadspace fraction. Its relationship with VD alv /VT alv is non-linear and all the factors tested (except cardiac output and anatomical deadspace fraction) caused significant deviation from the curve constructed at normal physiological conditions. This susceptibility to influence renders the interpretation even of trends in predicted alveolar deadspace fraction unreliable since change in the predicted value may be caused by alteration in many other factors. It was noted that the size of the additional "virtual deadspace' produced by the varying factors was related to an increase in P a CO 2 , prompting us to correct for this factor. The value (P a-E′ CO 2 )/P a CO 2 was thus examined.
The relationship between alveolar deadspace fraction and the value of (P a-E′ CO 2 )/P a CO 2 was more nearly linear (Equation 1: VD alv /VT alv =1.135x (P a-E′ CO 2 )/P a CO 2 -0.005, r=0.999). This has clinical importance since it allows relatively simple estimation of the deadspace fraction. It is also important to note that few physiological factors cause alteration in this relationship. This allows confidence in calculations in situations when these factors may be abnormal. The validity of estimating VD alv /VT alv using equation 1 is predicted by the NPS to be affected significantly only by the anatomical deadspace and pulmonary venous admixture fractions. Varying these factors caused deviation from the baseline curves.
As anatomical deadspace fraction increases, nonlinearity is encouraged in the relationship between VD alv /VT alv and (P a-E′ CO 2 )/P a CO 2 (Figure 2a ). The error in estimating VD alv /VT alv using equation 1 during variation in anatomical deadspace fraction is shown in Figure 3a . Large anatomical deadspace fractions produce an erroneous underestimation of VD alv /VT alv . It should be noted that this underestimation of VD alv /VT alv is related to its elevation by an increase in anatomical deadspace fraction. Large variations in anatomical deadspace fraction are rare in the clinical setting and significant variability in the individual at constant tidal volume is unlikely 6 . The variation in anatomical deadspace seen in clinical practice is unlikely to cause clinically important inaccuracy in alveolar deadspace estimation using equation 1.
Increasing pulmonary venous admixture causes a change in the gradient and intercept of the curve, although approximate linearity is retained ( Figure  2b ). Use of equation 1 to estimate VD alv /VT alv while pulmonary venous admixture increase generates an erroneous overestimation (Figure 3b ). It has been noted previously that pulmonary shunting of blood causes an apparent increase in the deadspace fraction 22, 23 , creating a "virtual deadspace" as described by Fletcher 24 . This may be seen in Figure 2b , where the intercept with the vertical axis rises with increasing pulmonary venous admixture. The error is greatest when pulmonary venous admixture is large and deadspace fraction is small (Figure 3b ). This situation is clinically easy to appreciate, and overestimation of VD alv /VT alv by equation 1 should be assumed in the hypoxaemic patient. Alternatively, estimation of the shunt fraction may be performed using iso-shunt diagrams 25 , Hope's approximation 26 or a physiological simulation such as the NPS 9 in the hypoxaemic patient and Figure 2b can then be used to estimate alveolar deadspace. Although existing methods, such as application of the Bohr-Enghoff equation to exhaled gases in conjunction with Fowler's technique, are likely to provide more accurate estimation of alveolar deadspace fraction, the use of equation 1 may prove simple and useful.
CONCLUSION
Use of the arterial to end-tidal CO 2 gradient (P a-E′ CO 2 ) to estimate alveolar deadspace fraction is unreliable since the relationship is non-linear and is influenced by many physiological factors. Estimation of alveolar deadspace using VD alv /VT alv =1.135x(P a-E′ CO 2 )/P a CO 2 -0.005 may provide a clinically valid and convenient bedside test. In those patients whose P a CO 2 and P E′ CO 2 are known, trends in (P a-E′ CO 2 )/P a CO 2 may provide a useful indicator of disease progress, the effect of therapeutic manoeuvres and of the patient's readiness to commence weaning from ventilation. The accuracy of VD alv /VT alv will be increased if correction for pulmonary venous admixture is undertaken in hypoxaemic patients using a simulator or iso-shunt curves. Clinical validation is required to support these findings since our study, while based upon validated physiological models, is theoretical.
